Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1979 1
1981 1
1984 1
1993 1
1994 1
1996 1
2000 1
2003 1
2004 1
2006 1
2007 1
2008 1
2010 1
2011 3
2012 1
2015 5
2016 2
2017 2
2018 2
2020 1
2021 4
2022 2
2023 2
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

34 results

Results by year

Filters applied: . Clear all
Page 1
Diagnosis and management of cutaneous lymphomas and lymphoid proliferations in children, adolescents and young adults (CAYA).
Stokke J, Tann A, El-Mallawany NK, Oschlies I. Stokke J, et al. Best Pract Res Clin Haematol. 2023 Mar;36(1):101448. doi: 10.1016/j.beha.2023.101448. Epub 2023 Feb 10. Best Pract Res Clin Haematol. 2023. PMID: 36907638 Review.
Although rare overall, cutaneous lymphomas/LPD occur in real-world settings and awareness of the differential diagnosis, potential complications, and various therapeutic approaches will help ensure the optimal diagnostic work-up and clinical management. ...Focus on the mos …
Although rare overall, cutaneous lymphomas/LPD occur in real-world settings and awareness of the differential diagnosis, potential complicat …
Diagnosis and Management of Cutaneous Lymphomas Including Cutaneous T-cell Lymphoma.
Zic JA. Zic JA. Med Clin North Am. 2021 Jul;105(4):737-755. doi: 10.1016/j.mcna.2021.04.010. Med Clin North Am. 2021. PMID: 34059248 Review.
The cutaneous B-cell lymphomas have fewer variants that often present as papules or nodules that can mimic nonmelanoma skin cancers. Some therapies for cutaneous lymphoma have unique side effects such as central hypothyroidism, hyperlipidemia, and peripheral neuropathy....
The cutaneous B-cell lymphomas have fewer variants that often present as papules or nodules that can mimic nonmelanoma skin cancers. Some …
Etiopathogenesis, Diagnosis, and Treatment Strategies for Lymphomatoid Papulosis with Particular Emphasis on the Role of the Immune System.
Nowicka D, Mertowska P, Mertowski S, Hymos A, Forma A, Michalski A, Morawska I, Hrynkiewicz R, Niedźwiedzka-Rystwej P, Grywalska E. Nowicka D, et al. Cells. 2022 Nov 21;11(22):3697. doi: 10.3390/cells11223697. Cells. 2022. PMID: 36429125 Free PMC article. Review.
Lymphomatoid papulosis (LyP) is a very rare disease that belongs to the group of CD30+ lymphoproliferative skin diseases. ...
Lymphomatoid papulosis (LyP) is a very rare disease that belongs to the group of CD30+ lymphoproliferative skin diseases. ...
Cutaneous CD30-positive T-cell lymphoproliferative disorders-clinical and histopathologic features, differential diagnosis, and treatment.
Kempf W, Kerl K, Mitteldorf C. Kempf W, et al. Semin Cutan Med Surg. 2018 Mar;37(1):24-29. doi: 10.12788/j.sder.2018.001. Semin Cutan Med Surg. 2018. PMID: 29719017 Review.
Cutaneous CD30+ T-cell lymphoproliferative disorders (CD30+ LPD) are the second most common form of cutaneous T-cell lymphoma. CD30+ LPD include lymphomatoid papulosis, primary cutaneous anaplastic large-cell lymphoma, and borderline lesions. ...Although the histolo …
Cutaneous CD30+ T-cell lymphoproliferative disorders (CD30+ LPD) are the second most common form of cutaneous T-cell lymphoma. CD30+ LPD inc …
First-line treatment in lymphomatoid papulosis: a retrospective multicentre study.
Fernández-de-Misa R, Hernández-Machín B, Servitje O, Valentí-Medina F, Maroñas-Jiménez L, Ortiz-Romero PL, Sánchez Schmidt J, Pujol RM, Gallardo F, Pau-Charles I, García Muret MP, Pérez Gala S, Román C, Cañueto J, Blanch Rius L, Izu R, Ortiz-Brugués A, Martí RM, Blanes M, Morillo M, Sánchez P, Peñate Y, Bastida J, Pérez Gil A, Lopez-Lerma I, Muniesa C, Estrach T. Fernández-de-Misa R, et al. Clin Exp Dermatol. 2018 Mar;43(2):137-143. doi: 10.1111/ced.13256. Epub 2017 Oct 10. Clin Exp Dermatol. 2018. PMID: 28994134 Free article.
BACKGROUND: Data regarding response to treatment in lymphomatoid papulosis (LyP) are scarce. AIM: To assess the daily clinical practice approach to LyP and the response to first-line treatments. ...Of the 252 patients, 31 (13%) had associated mycosis fungoides unrel …
BACKGROUND: Data regarding response to treatment in lymphomatoid papulosis (LyP) are scarce. AIM: To assess the daily clinical …
Practical Management of CD30+ Lymphoproliferative Disorders.
Hughey LC. Hughey LC. Dermatol Clin. 2015 Oct;33(4):819-33. doi: 10.1016/j.det.2015.05.013. Epub 2015 Aug 29. Dermatol Clin. 2015. PMID: 26433852 Free article. Review.
Although these LPDs are clinically heterogeneous, they can be indistinguishable histologically. Lymphomatoid papulosis rarely requires systemic treatment; however, multifocal primary cutaneous anaplastic large cell cutaneous lymphoma and large cell transformation of …
Although these LPDs are clinically heterogeneous, they can be indistinguishable histologically. Lymphomatoid papulosis rarely …
Histopathological aspects and differential diagnosis of CD8 positive lymphomatoid papulosis.
Marschalkó M, Gyöngyösi N, Noll J, Károlyi Z, Wikonkál N, Hársing J, Kuroli E, Csomor J, Matolcsy A, Sarolta K, Szepesi Á. Marschalkó M, et al. J Cutan Pathol. 2016 Nov;43(11):963-973. doi: 10.1111/cup.12779. Epub 2016 Aug 30. J Cutan Pathol. 2016. PMID: 27461449
Lymphomatoid papulosis (LyP) belongs to CD30+ lymphoproliferative disorders with indolent clinical course. ...
Lymphomatoid papulosis (LyP) belongs to CD30+ lymphoproliferative disorders with indolent clinical course. ...
CD30+ lymphoproliferative disorders: histopathology, differential diagnosis, new variants, and simulators.
Kempf W. Kempf W. J Cutan Pathol. 2006 Feb;33 Suppl 1:58-70. doi: 10.1111/j.0303-6987.2006.00548.x. J Cutan Pathol. 2006. PMID: 16412214 Review.
CD30+ lymphoproliferative disorders of the skin (CD30+ LPD) represent a well-defined spectrum of primary cutaneous T-cell lymphomas which have been recognized as distinct entities in recent lymphoma classifications. Lymphomatoid papulosis and anaplastic large-cell l …
CD30+ lymphoproliferative disorders of the skin (CD30+ LPD) represent a well-defined spectrum of primary cutaneous T-cell lymphomas which ha …
34 results